My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Illumina, Inc. - Common Stock (NQ:ILMN)

192.98 +3.51 (+1.85%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

38 39 Next >

Illumina Supports Norway's Pioneering Precision Medicine Study

December 17, 2021

SOURCE: Illumina

Via 3BL Media

Gretel and Illumina Partner to Develop Synthetic Data for Genomic Research

December 14, 2021

From Gretel

Via Business Wire

Amid Pandemic, Illumina Invests in 'Culture of Care'

December 10, 2021

SOURCE: Illumina

Via 3BL Media

Topics Supply Chain

Early Cancer Detection for Dogs Is Here

December 08, 2021

SOURCE: Illumina

Via 3BL Media

Illumina Selected As a Best Place to Work in Biopharma

November 30, 2021

SOURCE: Illumina

Via 3BL Media

Illumina Salutes Service Members on Veterans Day

November 12, 2021

SOURCE: Illumina

Via 3BL Media

Illumina Named Best for Vets Employer

November 05, 2021

SOURCE: Illumina

Via 3BL Media

Topics Supply Chain

Why Jim Cramer Likes Illumina, SoFi And More ↗

December 08, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc’s (NASDAQ:

Via Benzinga

GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test

December 06, 2021

From GRAIL, LLC

Via Business Wire

Illumina Ranked #2 on Newsweek's America's Most Responsible Companies 2022 List

December 03, 2021

SOURCE: Illumina

Via 3BL Media

Illumina and Sequoia Capital China Select First Startups to Join Genomics Incubator in China

December 02, 2021

SOURCE: Illumina

Via 3BL Media

Bionano Genomics Proves Not Everything Genetic is Gold ↗

December 01, 2021

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

Via InvestorPlace

10x Genomics Stock: Bull vs. Bear ↗

November 24, 2021

After a hot start, the stock has recently lagged the market. Is now a good time to buy?

Via The Motley Fool

Topics Initial Public Offering

Wait for Bionano Stock to Fall Further Before Buying ↗

November 23, 2021

BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term.

Via InvestorPlace

Proteomics Market Worth $55.9 Billion by 2026 - Size, Share, Developments, Opportunities, Key Players Analysis ↗

November 22, 2021

Northbrook, IL -- (SBWIRE) -- 11/22/2021 -- Proteomics Market Research Report Provides Crucial Industry Insights. Industry to Witness a Steady Growth in Near Future.

Via SBWire

Illumina's Shanghai Employees and Families Help Conserve Wetland Reserve

November 22, 2021

SOURCE: Illumina

Via 3BL Media

Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Major Statistics & Growth Dynamics ↗

November 19, 2021

Northbrook, IL -- (SBWIRE) -- 11/19/2021 -- Single-cell Analysis Market Research Report Provides Crucial Industry Insights. Industry to Witness a Steady Growth in Near Future.

Via SBWire

Following Rough Year, Is Burning Rock Set To Turn The Corner? ↗

November 18, 2021

Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China Cancer testing specialist’s...

Via Benzinga

Europe To Layout Objections to Illumina-Grail Deal: Bloomberg ↗

November 16, 2021

Illumina Inc (NASDAQ: ILMN) says the European Union will issue a list of objections tomorrow over the Company's $8B takeover of GRAIL, Bloomberg reports. Related...

Via Benzinga

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

November 16, 2021

SOURCE: Illumina

Via 3BL Media

Topics Religion

Illumina Named to 2021 Dow Jones Sustainability Indices With Highest Score in Pharmaceuticals, Biotechnology and Life Sciences Industry

November 15, 2021

SOURCE: Illumina

Via 3BL Media

Topics Stocks

Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand

November 11, 2021

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force...

Via FinancialNewsMedia

Bioinformatics Market Worth $21.8 Billion by 2026 - Size, Industry Trends, Key Players and Forecast ↗

November 10, 2021

Northbrook, IL -- (SBWIRE) -- 11/10/2021 -- Bioinformatics Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow.

Via SBWire

Illumina Clocks 40% Growth In Q3; Earnings Beat Expectations ↗

November 05, 2021

Illumina Inc (NASDAQ: ILMN) reported Q3 revenues of $1.11 billion, +40% Y/Y, beating the consensus of $1.04 billion. Consolidated Product revenues were $978 million,...

Via Benzinga

Topics Earnings

Illumina, inc (ILMN) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

ILMN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

After Its Grail Buyout, Illumina Beats Third-Quarter Expectations ↗

November 04, 2021

Illumina stock inched higher late Thursday after the company beat forecasts.

Via Investor's Business Daily

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative

November 04, 2021

SOURCE: Illumina

Via 3BL Media

Illumina Named a World's Top-Female Friendly Company by Forbes

November 03, 2021

SOURCE: Illumina

Via 3BL Media

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.